Clinical Trial Update: 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on short-term optimization of glucocorticosteroid treatment in patients with chronic drug-induced liver injury (DILI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Drugs mentioned

• glucocorticosteroid (glucocorticosteroid)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Drug-induced Liver Injury,Chronic | Phase 1, Phase 2 | Status: COMPLETED